Unicycive Therapeutics to Participate in H.C. Wainwright Kidney Virtual Conference

Discover the latest advancements in kidney disease treatments with Unicycive Therapeutics at the H.C. Wainwright 3rd Annual Kidney Virtual Conference. Join CEO Shalabh Gupta in a Fireside Chat on July 15, 2024, and learn about their lead drug candidate, oxylanthanum carbonate (OLC). With an eye on revolutionizing treatment for hyperphosphatemia in chronic kidney disease patients, Unicycive Therapeutics is at the forefront of biotechnology innovation. Don’t miss this exclusive opportunity to hear about their cutting-edge research and development. Visit Unicycive.com for more information.